Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Negative equity NBB
More debt than assets in 2 of the last 4 fiscal years.
-
Two loss years in a row NBB
Negative result in 2024 and 2025.
-
Tight liquidity NBB
Cash and receivables cover 3 % of short-term debt in 2025; threshold 65 %.
-
Busy address KBO
31 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
ENDO TOOLS THERAPEUTICS from Charleroi, company number BE0807570233, closed financial year 2025 with a result of € -9.9 million after tax. For that financial year ENDO TOOLS THERAPEUTICS recorded a gross margin of € -2.2 million and equity of € -15.1 million. Compared with financial year 2024, the result moved from € -5.7 million to € -9.9 million. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 23, 2026.
€ -15.1 million
▼ € 9.9 million vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -9.9 million
▼ 73 % more loss than in 2024
Profit after tax over the fiscal year.
€ 216,889
▼ 11% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -24.1 million.
People and assets in 2025
19.4
▼ 1.7 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 2.1 million
▼ 2% vs 2024
€ 106,200 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 2,302
▼ 59% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 18.8 million
▲ 112% vs 2024
€ 15.8 million is repaid this year. At this pace the long-term loan is gone in ≈ 1 years.
€ 1.2 million
▲ 36% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 161,580
▼ 6% vs 2024
Wages, holiday pay and social contributions still to pay. No outstanding taxes.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € -1,671,054 | € -2,325,458 | € -2,480,259 | € -2,238,685 | ▲ € 241,574 |
| Profit after taxes | € -3,546,722 | € -4,884,144 | € -5,735,982 | € -9,934,588 | ▼ € 4.2 million |
| Equity | € 5,493,311 | € 609,167 | € -5,126,815 | € -15,061,403 | ▼ € 9.9 million |
| Total debts | € 3,652,446 | € 4,921,016 | € 9,936,279 | € 20,167,873 | ▲ 103% |
| Cash | € 6,149,854 | € 442,722 | € 243,955 | € 216,889 | ▼ 11% |
| Retained profit | € -3,546,722 | € -8,430,866 | € -14,166,848 | € -24,101,437 | ▼ € 9.9 million |
| Bank debt | € 2,926,615 | € 3,507,115 | € 8,850,673 | € 18,763,855 | ▲ 112% |
| Balance sheet total | € 9,145,757 | € 5,530,183 | € 4,809,464 | € 5,106,470 | ▲ 6% |
| Employees (FTE) | 11.4 | 16.9 | 21.1 | 19.4 | ▼ 1.7 |
Key figures of ENDO TOOLS THERAPEUTICS, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to ENDO TOOLS THERAPEUTICS?
What happened at ENDO TOOLS THERAPEUTICS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- MV Lifesciences SRL stepped down as director. NBB
- New annual accounts for financial year 2025: loss of € 9.9 million. Source: NBB ↗
- ODMC stepped down as director. NBB
- DG International Consulting stepped down as director. NBB
- Endomundi stepped down as director. NBB
- Mercury Leader and Management sprl stepped down as director. NBB
- Alexandre Chau stepped down as director. NBB
- Old Mill Invest sprl stepped down as director. NBB
In short
From € 3.5 million loss in 2022 to € 9.9 million loss in 2025.
Management
The stake of CHAGRAL INVEST, EPIMEDE comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
ENDO TOOLS THERAPEUTICSThe shares are held by CHAGRAL INVEST (49.6%) and EPIMEDE (13.2%). It owns 100% of Endo Tools Therapeutics US Corp. itself.
Directors
According to the 2025 annual accounts
Director · represented by Olivier Delporte
Also active at: INTRESSA VASCULAR, Miracor Medical, Samantree Medical
· until 2026
Chairman of the board · represented by Denis Gestin
Also active at: INTRESSA VASCULAR, SYNERGIA MEDICAL
since 2019 · until 2026
Director · represented by Vincent Huberty
since 2019 · until 2026
Mercury Leader and Management sprl
Director · represented by Philippe Jean-Marie Léopold Degeer
Also active at: OPTEC, LASER ENGINEERING APPLICATIONS
since 2018 · until 2026
since 2022 · until 2028
Alexandre Chau
Managing director
since 2020 · until 2026
since 2018 · until 2026
since 2020 · until 2026
Shareholders
49.6%
13.2%
Participations
Endo Tools Therapeutics US Corp.
100%
Establishments
Establishment units
Physical locations of this company
Rue Clément Ader 10
6041 Charleroi
Researchdreef 12
1070 Anderlecht
Active since 12 September 2016
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 31 companies are registered at this address.
All companies at this address →Brussels South Charleroi BioPark Dev
€ 80,186 gross margin · 2025
ImmunXperts
€ 393,338 gross margin · 2024
LYS MEDICAL
€ -309,203 gross margin · 2025
SPECTRALYS BIOTECH
€ 143,689 gross margin · 2025
ProtonW.be
€ -7,643 gross margin · 2025
+26 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Hosting & Email
Email provider
Microsoft 365
Hosting
OVH, FR
DNS
OVH DNS
Website info
Features
Security
Details
- Company number
- 0807.570.233
- VAT number
- BE 0807.570.233
- Registered office
- Rue Clément Ader 10, 6041 Charleroi
- Names & denominations
- ENDO TOOLS THERAPEUTICS
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 29 October 2008
- Peppol
- Active · Active since 21 Oct 2026
- Contact
- endotools.be [email protected] +3271919409
- Activities · NACE
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied
Activiteiten op het gebied van voeding
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied
Overige menselijke gezondheidszorg, n.e.g.
Overige activiteiten van vrije beroepen en andere wetenschappelijke en technische activiteiten, neg
Vervaardiging van medische en tandheelkundige instrumenten en benodigdheden
Overige gespecialiseerde wetenschappelijke en technische activiteiten